Headache News and Research

Latest Headache News and Research

Dietary influences on long COVID in children

A new study discusses possible mechanisms of long COVID in children and how they might relate to their dietary intake of important vitamins and elements.

13 Apr 2022

When symptoms linger for weeks, is it long covid?

Many Americans are discovering that recovering from covid-19 may take weeks or even months longer than expected, leaving them with lingering symptoms like intense fatigue or a racing pulse. But does that mean they have what's known as long covid?

13 Apr 2022

Review: 52% of the global population affected by headache disorder every year

A new review of the evidence suggests 52% of the global population are affected by a headache disorder every year, with 14% reporting migraines. The review is published in The Journal of Headache and Pain.

12 Apr 2022

Safety, reactogenicity, and immunogenicity of the BNT and half-m1273 mRNA COVID-19 vaccines given as a fourth dose booster

Researchers evaluated the immunogenicity of Pfizer’s BNT162b2 and Moderna’s mRNA-1273 vaccines offered as the fourth dose against SARS-CoV-2.

12 Apr 2022

Differences in symptoms and risk of hospitalization following infection with Omicron or Delta SARS-CoV-2 variants among vaccinated people

A recent study assessed the prevalence of SARS-CoV-2 symptoms and the risk of hospitalization in vaccinated individuals infected with SARS-CoV-2 Omicron and Delta variants.

12 Apr 2022

Chromatin accessibility as an early marker of severe COVID-19

A new study explores the possible use of chromatin remodeling in predicting a severe clinical trajectory for COVID-19.

11 Apr 2022

Scientists are searching for the ‘perfect protein’ to develop mRNA-based malaria vaccine

After the success of mRNA vaccines against COVID-19, scientists are cautiously optimistic that the same technology can be used to tackle other widespread diseases such as malaria.

7 Apr 2022

People with some types of epilepsy may have a lower quality of life, study suggests

A new study suggests that people with epilepsy associated with head injuries, especially the type not well controlled by medication, are more likely to have other health conditions like depression, post-traumatic stress disorder (PTSD), back pain and headache that may result in them reporting a lower quality of life.

6 Apr 2022

Study explores incidence of cardiac impairment a year after SARS-CoV-2 infection

Researchers used cardiac magnetic resonance to show the one-year trajectory of cardiac impairment in long coronavirus disease patients.

6 Apr 2022

Insights into the pathophysiology of NeuroCOVID

A new study describes the neurological features of COVID-19, both short- and long-term.

6 Apr 2022

Researchers explore the link between immunoglobulins and blood profile in severe SARS-CoV-2 patients

A new study illustrated the association of immunoglobulins with blood characteristics in COVID-19 patients.

6 Apr 2022

Researchers identify novel SARS-CoV-2 Delta-Omicron recombinant strain in Europe

A new study presented the rapid profiling of a SARS-CoV-2 Delta-Omicron recombinant sequence from Europe.

6 Apr 2022

COVID-19 can cause inflammation and bleeding in the brain

A new study published in Nature Communications investigates SARS-CoV-2-infected non-human primates (NHPs) to understand the neurological symptoms associated with "long COVID."

6 Apr 2022

Swedish HCW study shows COVID booster shots have limited effect on Omicron

Researchers examine emerging infections in healthcare workers who received the booster vaccination either with or without prior SARS-CoV-2 infection.

5 Apr 2022

Case study of multi-system inflammatory syndrome in children in a fully vaccinated teenager

A new preprint describes the importance of recognizing this complication, reporting a case of MIS-C without a prior history of this infection.

4 Apr 2022

Investigational new drug may be safe for patients with mild cognitive impairment, dementia

A small, preliminary study of an investigational new drug being studied for mild cognitive impairment and mild dementia associated with Alzheimer's disease suggests it is safe and may be associated with improvements in executive function, thinking and memory skills.

31 Mar 2022

Headache News and Research

Latest Headache News and Research

Dietary influences on long COVID in children

When symptoms linger for weeks, is it long covid?

Review: 52% of the global population affected by headache disorder every year

Safety, reactogenicity, and immunogenicity of the BNT and half-m1273 mRNA COVID-19 vaccines given as a fourth dose booster

Differences in symptoms and risk of hospitalization following infection with Omicron or Delta SARS-CoV-2 variants among vaccinated people

Chromatin accessibility as an early marker of severe COVID-19

Scientists are searching for the ‘perfect protein’ to develop mRNA-based malaria vaccine

People with some types of epilepsy may have a lower quality of life, study suggests

Study explores incidence of cardiac impairment a year after SARS-CoV-2 infection

Insights into the pathophysiology of NeuroCOVID

Researchers explore the link between immunoglobulins and blood profile in severe SARS-CoV-2 patients

Researchers identify novel SARS-CoV-2 Delta-Omicron recombinant strain in Europe

COVID-19 can cause inflammation and bleeding in the brain

Swedish HCW study shows COVID booster shots have limited effect on Omicron

Case study of multi-system inflammatory syndrome in children in a fully vaccinated teenager

Investigational new drug may be safe for patients with mild cognitive impairment, dementia

Preclinical investigation of intranasal adjuvanted COVID-19 vaccine

Trigeminal ganglia cell atlas implicates several cell types in migraine

Anti-spike SARS-CoV-2 antibody titer trends over 15 months in healthcare workers in Boston

Study evaluates the effectiveness of lactobacilli throat sprays against COVID-19

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Headache News and Research

Latest Headache News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in